MX2022004056A - Composicion novedosa para el cuidado de la piel. - Google Patents
Composicion novedosa para el cuidado de la piel.Info
- Publication number
- MX2022004056A MX2022004056A MX2022004056A MX2022004056A MX2022004056A MX 2022004056 A MX2022004056 A MX 2022004056A MX 2022004056 A MX2022004056 A MX 2022004056A MX 2022004056 A MX2022004056 A MX 2022004056A MX 2022004056 A MX2022004056 A MX 2022004056A
- Authority
- MX
- Mexico
- Prior art keywords
- skin care
- care composition
- acnes
- skin
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere en general al campo del cuidado de la piel. Más particularmente, la invención se refiere a una composición para el cuidado de la piel cosmética o terapéutica que comprende bacterias vivas de al menos una cepa de Cutibacterium acnes (C. acnes) en combinación con un emoliente que apoya específicamente su viabilidad durante el almacenamiento y/o su capacidad de replicación después de su aplicación en la piel. Preferentemente, la composición para el cuidado de la piel cosmética o terapéutica comprende bacterias de al menos 10 una cepa de C. acnes seleccionada del grupo que consiste en D1, A5, C1, C3, H1, H2, H3, K1, K2, K4, K6, K8, K9, L1 y F4. La invención también proporciona un método para tratar o prevenir el acné mediante la aplicación de la composición para el cuidado de la piel de la invención en una zona de la piel que necesita tratamiento. La invención también se refiere al uso de una composición para el cuidado de la piel de la invención para tratar o prevenir el acné.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19201251 | 2019-10-03 | ||
PCT/EP2019/085875 WO2021063527A1 (en) | 2019-10-03 | 2019-12-18 | Novel skin care composition |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022004056A true MX2022004056A (es) | 2022-05-02 |
Family
ID=68137887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022004056A MX2022004056A (es) | 2019-10-03 | 2019-12-18 | Composicion novedosa para el cuidado de la piel. |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220395451A1 (es) |
EP (1) | EP4037646A1 (es) |
CN (1) | CN114901245A (es) |
BR (1) | BR112022006345A2 (es) |
MX (1) | MX2022004056A (es) |
WO (1) | WO2021063527A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3285872A4 (en) | 2015-04-20 | 2019-02-20 | S-Biomedic NV | METHODS AND COMPOSITIONS FOR MODIFYING THE COMPOSITION OF THE SKIN MICROBIOMA USING COMPLEX MIXTURES OF BACTERIAL STRAINS |
MX2019004611A (es) | 2016-10-19 | 2019-09-18 | S Biomedic Nv | Metodos y composiciones para cambiar la composicion del microbioma de la piel usando mezclas complejas de cepas bacterianas. |
WO2023110886A1 (en) * | 2021-12-17 | 2023-06-22 | S-Biomedic | A freeze-dried composition and preparation thereof |
EP4197523A1 (en) * | 2021-12-17 | 2023-06-21 | DSM IP Assets B.V. | A freeze-dried composition and preparation thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743609B1 (en) | 1997-12-23 | 2004-06-01 | Arkion Life Sciences Llc | Linoleate isomerase |
EP3061501A1 (en) * | 2015-02-27 | 2016-08-31 | Rottapharm Ltd. | Composition for the treatment of acne |
EP3285872A4 (en) | 2015-04-20 | 2019-02-20 | S-Biomedic NV | METHODS AND COMPOSITIONS FOR MODIFYING THE COMPOSITION OF THE SKIN MICROBIOMA USING COMPLEX MIXTURES OF BACTERIAL STRAINS |
GB201520638D0 (en) * | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
JP2019514885A (ja) * | 2016-04-21 | 2019-06-06 | ネイキッド バイオーム,インク. | 皮膚障害の処置のための組成物および方法 |
MX2019004611A (es) | 2016-10-19 | 2019-09-18 | S Biomedic Nv | Metodos y composiciones para cambiar la composicion del microbioma de la piel usando mezclas complejas de cepas bacterianas. |
DE102016012651A1 (de) | 2016-10-24 | 2018-04-26 | Beiersdorf Ag | Mehrkomponentenapplikator |
EP3538119A4 (en) * | 2016-11-08 | 2020-07-01 | The Regents of The University of California | COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES AND MAINTAINING HEALTHY SKIN |
-
2019
- 2019-12-18 WO PCT/EP2019/085875 patent/WO2021063527A1/en unknown
- 2019-12-18 MX MX2022004056A patent/MX2022004056A/es unknown
- 2019-12-18 US US17/754,427 patent/US20220395451A1/en active Pending
- 2019-12-18 BR BR112022006345A patent/BR112022006345A2/pt unknown
- 2019-12-18 EP EP19829125.4A patent/EP4037646A1/en active Pending
- 2019-12-18 CN CN201980101000.1A patent/CN114901245A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4037646A1 (en) | 2022-08-10 |
BR112022006345A2 (pt) | 2022-06-28 |
US20220395451A1 (en) | 2022-12-15 |
WO2021063527A1 (en) | 2021-04-08 |
CN114901245A (zh) | 2022-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022004051A (es) | Composicion novedosa para el cuidado de la piel. | |
MX2022004056A (es) | Composicion novedosa para el cuidado de la piel. | |
MX2022004054A (es) | Composicion novedosa para el cuidado de la piel. | |
MX2022004052A (es) | Composicion novedosa para el cuidado de la piel. | |
MX2022004055A (es) | Composicion novedosa para el cuidado de la piel. | |
AR109605A2 (es) | Método para tratar enfermedades vasculares periféricas, composición y utilización | |
PH12018502634A1 (en) | Topical compositions of apremilast | |
PH12018501988A1 (en) | Agent for increasing intestinal butyric acid and proliferation agent for butyric acid-producing bacteria | |
Spaas et al. | The effects of equine peripheral blood stem cells on cutaneous wound healing: a clinical evaluation in four horses | |
MX2021005755A (es) | Composiciones para el tratamiento de enfermedades de la piel y envejecimiento de la piel asociados al estres oxidativo y diagnostico de enfermedades de la piel asociadas con estres oxidativo. | |
MX2021010058A (es) | Formulaciones de rapamicina tópicas y su uso en el tratamiento de angiofibromas faciales y otros trastornos de la piel. | |
MX2022004048A (es) | Composicion novedosa para el cuidado de la piel. | |
RU2014150505A (ru) | Способ идентификации лигандов рецептора ahr, которые обладают терапевтической себосупрессивной активностью, и указанные лиганды | |
MX2022004050A (es) | Composicion novedosa para el cuidado de la piel. | |
MX2020011817A (es) | Metodos para tratar el linfoma. | |
CR20220215A (es) | Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1 | |
CR20220329A (es) | Anticuerpos anti–mertk y metodos de uso de los mismos | |
MX2022006533A (es) | Un esteroide c21-n-pirazolilo 19-nor c3,3-disustituido y metodos de uso del mismo. | |
MX2021004207A (es) | Uso de reboxetina para el tratamiento de narcolepsia. | |
BR112013011064A2 (pt) | uso cosmético nutracêutico ou oral e processo de tratamento cosmético oral | |
MX2023000868A (es) | Derivado de isoindolina que contiene azufre, metodo de preparacion y uso medico del mismo. | |
MX2022002245A (es) | Compuesto y metodos para tratar enfermedades relacionadas con oxalato. | |
WO2020016655A3 (en) | Treatment of neuropathy with dna constructs expressing igf-1 isoforms | |
SG11201909144VA (en) | Bacterial secretome for use in the treatment of skin lesions | |
EP3632450A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A DISEASE CAUSING FOOT PAIN CONSISTING OF BOTULIC TOXIN AND HYALURONIC ACID AND METHOD OF TREATMENT OF FOOT PAIN USING THE SAME |